Elimination of hepatitis c in Turkey

Basit Öğe Kaydı
dc.authorid0000-0002-8909-2102
dc.contributor.authorÖrmeci, Necati
dc.contributor.editorMusabaev, Erkin Isakovich
dc.date.accessioned2026-01-06T11:49:40Z
dc.date.available2026-01-06T11:49:40Z
dc.date.issued2025
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractThis manuscript examines the epidemiological patterns, transmission routes, and genotypic distribution of hepatitis C virus (HCV) in Türkiye, highlighting national progress toward elimination targets set by the World Health Organization (WHO). The main objective is to evaluate the effectiveness of national screening, diagnostic, and treatment strategies, with a focus on the scale-up of direct-acting antiviral (DAA) therapies and their associated cost-effectiveness. Drawing on recent multicenter and population-based studies, the paper outlines the shifting prevalence of HCV geno types, particularly among high-risk populations such as people who inject drugs (PWID), prisoners, and individuals undergoing hemodialysis. The analysis demon strates that genotype 1b remains predominant, though genotype diversity is increas ing due to migration and changing transmission dynamics. Findings reveal that despite improved availability of DAA treatments and health policy initiatives like the 2018–2023 National Viral Hepatitis Program, gaps persist in diagnostic follow-up and referral. The manuscript emphasizes the dual approach of micro- and macro elimination, advocating for integrated care models, increased physician engagement, and enhanced awareness efforts. Projections suggest that achieving WHO goals is feasible in Türkiye if testing and treatment rates significantly improve. Ultimately, this study underscores the necessity of sustained political commitment, intersectoral collaboration, and targeted public-health interventions to reduce HCV-related mor bidity and mortality by 2030.
dc.identifier.citationÖrmeci, N. (2025). Elimination of hepatitis c in Turkey. E. I. Musabaev (Ed.), Viral Hepatit B ve C'nin Ortadan Kaldırılması - Küresel Girişimler, Ulusal Programlar ve Bilimsel Gelişmeler (ss. 1-22). London: IntechOpen. https://doi.org/10.5772/intechopen.115657
dc.identifier.doi10.5772/intechopen.115657
dc.identifier.endpage22
dc.identifier.isbn9781806321018
dc.identifier.isbn9781806321025
dc.identifier.isbn9781806321032
dc.identifier.startpage1
dc.identifier.urihttps://doi.org/10.5772/intechopen.115657
dc.identifier.urihttps://hdl.handle.net/20.500.13055/1230
dc.institutionauthorÖrmeci, Necati
dc.institutionauthorid0000-0002-8909-2102
dc.language.isoen
dc.publisherIntechOpen
dc.relation.ispartofViral Hepatit B ve C'nin Ortadan Kaldırılması - Küresel Girişimler, Ulusal Programlar ve Bilimsel Gelişmeler
dc.relation.publicationcategoryKitap Bölümü - Ulusal
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHepatitis C Virus
dc.subjectGenotypes
dc.subjectDirect-Acting Antiviral Drugs
dc.subjectCost-Effectiveness Analyses
dc.subjectTurkey
dc.titleElimination of hepatitis c in Turkey
dc.title.alternativeTürkiye'de hepatit c'nin ortadan kaldırılması
dc.typeBook Chapter
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
2.06 MB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Bölümü Koleksiyonu